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TO THE EDITOR
Psoriasis is a prototype for chronic
inflammatory skin disease mediated by
activated T cells showing T helper type
1 (Th1)/Th17 dominance (Di Cesare
et al., 2009). In lesional psoriasis, a
markedly increased number of prolife-
rating memory-type T cells has been
observed, suggesting their continuous
activation by lesional antigen-present-
ing cells (Bos et al., 1989; Morganroth
et al., 1991; Chang et al., 1992). In
the psoriatic dermis, populations of
mature myeloid dendritic cells (DCs)
are characterized by expressing
DC-lysosomal-associated membrane
protein (DC-LAMP/CD208), and they
characteristically aggregate together
with the infiltrating T cells mimicking
the T-cell areas of secondary lymphoid
organs (Zaba et al., 2007). These ectopic
lymphoid structures have been reported
in peripheral non-lymphoid tissues
during local infection and inflamma-
tion (Katou et al., 2000; Page et al.,
2002; Zaba et al., 2007), and are
thought to act as the nidus that
contributes to disease progression by
autoantigen presentation and activation
of T cells in situ (Carragher et al., 2008;
Weyand et al., 2001). In this regard,
knowing the molecular mechanisms
involved in the formation of dermal
aggregates of mature DCs and T cells
in psoriasis may be important for further
understanding of chronic inflammation
(Guttman-Yassky et al., 2011).
Psoriatic lesions contain abundant
epithelial CC chemokine 20 (CCL20)
and dermal CC chemokine receptor 6
(CCR6)-expressing skin-homing T cells,
which are crucial for psoriasis
pathogenesis (Homey et al., 2000;
Hedrick et al., 2009). Previous studies
have established the possible
association of the CCL20/CCR6
chemokine system with peripheral
lymphoid structures in the chronically
inflamed epithelial tissues (Page et al.,
2002). Thus, our study was aimed to
assess whether this crucial CCL20/CCR6
pair is also related to the characteristic
cellular aggregates present in chronic
psoriatic lesions, and in turn, to suggest
a potential therapeutic target for
controlling chronic inflammation.
To obtain an insight into the cellular
location of CCR6þ cells, we performed
a series of immunohistochemical stu-
dies. We found significantly greater
numbers of both CCR6þ and CCR7þ
cells with aggregate patterns in lesional
psoriatic skin (Supplementary Figure S1
online). With existing previous data
showing the association of the CCL19/
CCR7 chemokine system in psoriatic
dermal aggregates (Mitsui et al., 2012),
we sought to demonstrate the possible
existence of the CCL20/CCR6 system in
these cellular structures.
To identify the cellular distribution of
CCR6 in lesional psoriasis, we used
double-label immunofluorescence. We
found that significant numbers of dermal
HLA-DRþ or CD11cþ antigen-pre-
senting DCs and CD3þ infiltrating
T cells expressed CCR6 (Figure 1a).
Interestingly, CCR6þ dermal DCs pre-
sented an unexpected aggregate pattern,
which resembled DC-LAMPþ mature
psoriatic DCs (Zaba et al., 2007). Thus
we decided to analyze CCR6 expression
in DC-LAMPþ cells. Importantly, almost
all of the DC-LAMPþ mature DCs co-
expressed CCR6 in the psoriatic dermis
(Figure 1b). To compare the level of
CCR6 expression between immature
and mature DCs, we prepared dermal
single cell suspensions from normal
and psoriatic skin and performed
flow cytometry. We found that the
dermal CD11cþHLA-DRþDC-LAMPþ
mature DCs specifically expressed
CCR6; however, DC-LAMPDCs
were devoid of CCR6 (Figure 1c).
These results suggest that psoriatic
CCR6þ mature DCs could aggregate
with CCR6þ T cells and continuously
activate them. Thus, the CCL20/CCR6
chemokine system may be another
candidate that induces the formationAccepted article preview online 13 December 2013; published online 9 January 2014
Abbreviations: CCL20, CC chemokine 20; CCR6, CC chemokine receptor 6; DC, dendritic cell; DC-LAMP,
DC-lysosomal-associated membrane protein
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of dermal aggregates in chronic
psoriasis.
With the acquirement of data on
CCR6 expression in psoriatic dermal
DC-LAMPþ DCs and infiltrating aggre-
gated T cells, additional exploration on its
counterpart ligand CCL20 was performed.
In the psoriatic plaque, keratinocytes are
known to actively express CCL20, which
is induced through IL-17 signaling
(Chiricozzi et al., 2011). However, it has
been previously reported that IL-17þ
Th17 cells also express CCL20, which
function to attract other CCR6þ cells,
suggesting that they may be another
important cellular source for CCL20 in
Th17-associated diseases (Maddur et al.,
2011). First, we showed that not only the
human peripheral Th17 subset, but also
the Th1 and Th22 subsets could express
CCL20 upon stimulation (Supplemen-
tary Figure S2 online). To identify the
cellular location of CCL20 in psoriatic
skin, we performed double-label
immunofluorescence staining. Psoriatic
epidermal keratinocytes prominently
expressed CCL20 compared with nor-
mal keratinocytes as reported previously
(Figure 2). Interestingly, CD11cþ der-
mal DCs partially co-expressed CCL20
and there was abundant co-expression
of CCL20 in CD3þ dermal-infiltrating T
cells, suggesting that DCs and T cells are
significant reservoirs of CCL20 in psor-
iatic skin. This result indicates that the
fraction of dermal CCL20þ myeloid
DCs and T cells could be a cellular
nidus for attracting CCR6þ mature DCs
and T cells leading to the formation of
immunologic cellular aggregates. In
contrast, there were no cellular sources
for CCL20 in the normal dermis,
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Figure 1. DC-LAMPþ dermal dendritic cells (DCs) and T cells in the psoriatic dermis expressed CC chemokine receptor 6 (CCR6) in the characteristic
aggregating pattern. (a) Fraction of HLA-DRþ (left), CD11cþ (middle) dermal myeloid DCs, and a large group of CD3þ (right) infiltrating T cells expressed
CCR6 and showed an aggregating pattern. (b) Most dendritic cell-lysosomal-associated membrane protein (DC-LAMP)þ mature dermal DCs in psoriasis co-
expressed CCR6 and intermingled with other CCR6þ cells. (c) Flow cytometric analysis of the dermal single cells from the normal and the psoriatic skin revealed
that CCR6 expression was confined to the DC-LAMPþ mature DCs (HLA-DRþCD11cþDC-LAMPþ cells), and that immature DCs (HLA-DRþCD11cþDC-
LAMP– cells) were devoid of CCR6 (red line: isotype control, blue line: CCR6 stained). White arrows indicate the double-positive cells. Bar¼ 100mm.
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probably associated with the lack of
lymphoid clusters in the normal skin.
Finally, we sought to evaluate the
correlation of DC-LAMPþ mature DCs
and the severity of the inflammatory
cutaneous lesions. We demonstrated
the presence of a significantly greater
number of DC-LAMPþ mature DCs in
chronic psoriatic plaques compared with
other acute papulosquamous dermatoses
(Supplementary Figure S3a online).
Notably, characteristic aggregates of
DC-LAMPþ mature DCs were mainly
observed in chronic psoriasis. Clinical
induration scores of psoriatic plaques
significantly correlated to the number
of infiltrating DC-LAMPþ cells, hinting
at their association with disease
severity and chronicity (Supplementary
Figure S3b online).
Our current study showed grouping
tendencies of DC-LAMPþ mature DCs
and lesional T cells in the dermal part of
psoriatic skin, and that these dermal
aggregates contain CCR6-bearing
mature DCs and T cells. With persuasive
evidence that lesional DCs and T cells
not only bear CCR6 but also express its
ligand CCL20, the CCL20/CCR6 chemo-
kine system may be crucial in self-
maintaining the interaction between
lesional mature DCs and T cells wherein
T cells are effectively activated in situ.
In turn, we believe that the aggregates
of DC-LAMPþ mature DCs and T cells
typically contribute to the chronic
nature of psoriasis compared with other
acute skin lesions. We therefore con-
clude that the CCL20/CCR6 chemokine
system may be a prospective target for
the treatment of chronic psoriasis via
inhibiting the immunological synapse
between pathologic DCs and T cells.
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Figure 2. Myeloid DCs and T cells were the cellular sources for CC chemokine 20 (CCL20) in psoriatic dermis. (a) Dermal CD11cþ DCs did not
co-express CCL20 in the normal skin (left); however, psoriatic skin contained some CCL20þ dermal myeloid DCs (right). Note the lack of CCL20 in the normal
epidermis, in contrast to the prominent CCL20 staining seen in the psoriatic keratinocytes. (b) CD3þ dermal T cells were devoid of CCL20 in the normal skin (left),
but the infiltrating T cells of the psoriatic skin expressed abundant CCL20 (right). White line denotes dermoepidermal junction. Bar¼ 100mm.
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TO THE EDITOR
Adenosine triphosphate (ATP) functions
as a chemical transmitter in almost
all types of cells, including skin cells
(Burnstock, 2007). Previously, we showed
that normal human epidermal keratino-
cytes (NHEKs) release ATP that mediates
inter-keratinocytic as well as keratino-
cyte-to-sensory communications via
P2Y2 receptors (Koizumi et al., 2004),
suggesting that ATP/P2 receptor-media-
ted signals in keratinocytes should be
important as both autocrine and parac-
rine signals in the skin. However, the
mechanism(s) underlying ATP release is
still a matter of debate. Recently, we iden-
tified SLC17A9 as a vesicular nucleotide
transporter (VNUT) that transports cyto-
solic ATP into vesicles (Sawada et al.,
2008). After this discovery, VNUT was
found to be essential for ATP exocytosis
in T cells (Tokunaga et al., 2010), neurons
(Larsson et al., 2012), and microglia
(Imura et al., 2013). As for skin cells, a
recent report showed that VNUT is
present in esophageal cells (Mihara
et al., 2011), but its function in epi-
dermal keratinocytes remained unknown.
First, NHEKs were stimulated with the
Ca2þ ionophore ionomycin for 20 min-
utes, and then the supernatant was col-
lected to measure the bulk release of ATP
from NHEKs. As shown in Supplemen-
tary Figure S1 online, the ionomycin-
evoked ATP release was dependent on
Ca2þ and vesicles. The pannexin/con-
nexin hemi-channel inhibitor, carbenox-
olone (at 10mM) had no effect on ATP
release (see caption of Supplementary
Figure S1 online). Thus, NHEKs appear
to release ATP by exocytosis.
Next, we tested the involvement of
VNUT in the ATP release. VNUT-posi-
tive signals were observed throughout
the epidermis, but were stronger in theAccepted article preview online 29 November 2013; published online 2 January 2014
Abbreviations: ATP, adenosine triphosphate; MANT-ATP, 20-/30-O-(N’-methylanthraniloyl) adenosine-50-
O-triphosphate, trisodium salt; MS, mechanical stimulation; NHEKs, normal human epidermal
keratinocytes; RFP, red fluorescent protein; VNUT, vesicular nucleotide transporter
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